drugset / Trial / NCT06284876
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To demonstrate the non-inferiority of Ilaprazole 10 mg to the active control in prevention of NSAIDs-associated peptic ulcer, as assessed by the proportion of subjects with peptic ulcer by Week 24
Timeline
- Start
- 2024-07-23
- Primary completion
- 2026-08-30
- Completion
- 2027-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ilaprazole | Small molecule | 10 mg | Oral |
| Subject | Lansoprazole | Other / unclassified | 15 mg | Oral |